Broadfin Capital, LLC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$4,207,000
-2.6%
1,611,999
-38.4%
0.87%
+53.0%
Q4 2018$4,321,0002,618,8190.57%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 666,729$14,008,0009.60%
DSC Advisors, L.P. 907,358$17,157,0008.33%
DAFNA Capital Management LLC 63,400$1,332,0001.32%
WALL STREET ASSOCIATES 199,343$4,188,0000.80%
Perceptive Advisors 742,132$15,592,0000.62%
EMERALD MUTUAL FUND ADVISERS TRUST 331,142$6,957,0000.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 458,332$9,630,0000.37%
EMERALD ADVISERS, LLC 321,313$6,751,0000.35%
Tourbillon Capital Partners, L.P. 611,686$12,852,0000.34%
DSC Advisors, L.P. 31,240$656,0000.32%
View complete list of NEOS THERAPEUTICS INC shareholders